Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Véronique Orian-Rousseau

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Frontiers in Immunology|April 24, 2015
CD44 Acts as a Signaling Platform Controlling Tumor Progression and MetastasisVéronique Orian-Rousseau
European Journal of Cancer (Oxford, England : 1990)|March 23, 2010
CD44, a therapeutic target for metastasising tumoursVéronique Orian-Rousseau
Advances in Cancer Research|August 2, 2014
CD44 is a multidomain signaling platform that integrates extracellular matrix cues with growth factor and cytokine signalsVéronique Orian-Rousseau, Jonathan Sleeman
Advances in Cancer Research|December 6, 2008
Adhesion proteins meet receptors: a common theme?Véronique Orian-Rousseau, Helmut Ponta
Molecular & Cellular Oncology|June 17, 2016
CD44 regulates Wnt signaling at the level of LRP6Véronique Orian-Rousseau, Mark Schmitt
Cancer Research|July 19, 2005
A five-amino-acid peptide blocks Met- and Ron-dependent cell migrationAlexandra Matzke, Peter Herrlich, Helmut Ponta, et al.
Plos One|January 28, 2014
Endocytosis of Fgf8 is a double-stage process and regulates spreading and signalingCharanya Rengarajan, Alexandra Matzke, Luisa Reiner, et al.
Communications Biology|July 17, 2024
High-throughput screening for cell binding and repulsion peptides on multifunctionalized surfacesSteffen J Sonnentag, Felix Jenne, Véronique Orian-Rousseau, et al.
Genes & Development|December 5, 2002
CD44 is required for two consecutive steps in HGF/c-Met signalingVéronique Orian-Rousseau, Linfeng Chen, Jonathan P Sleeman, et al.
Cancers|March 6, 2021
Plasticity in Colorectal Cancer: Why Cancer Cells DifferentiateRomina Judith Walter, Steffen Joachim Sonnentag, Véronique Orian-Rousseau, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Frontiers in Immunology|April 24, 2015
CD44 Acts as a Signaling Platform Controlling Tumor Progression and MetastasisVéronique Orian-Rousseau
European Journal of Cancer (Oxford, England : 1990)|March 23, 2010
CD44, a therapeutic target for metastasising tumoursVéronique Orian-Rousseau
Advances in Cancer Research|August 2, 2014
CD44 is a multidomain signaling platform that integrates extracellular matrix cues with growth factor and cytokine signalsVéronique Orian-Rousseau, Jonathan Sleeman
Advances in Cancer Research|December 6, 2008
Adhesion proteins meet receptors: a common theme?Véronique Orian-Rousseau, Helmut Ponta
Molecular & Cellular Oncology|June 17, 2016
CD44 regulates Wnt signaling at the level of LRP6Véronique Orian-Rousseau, Mark Schmitt
Cancer Research|July 19, 2005
A five-amino-acid peptide blocks Met- and Ron-dependent cell migrationAlexandra Matzke, Peter Herrlich, Helmut Ponta, et al.
Plos One|January 28, 2014
Endocytosis of Fgf8 is a double-stage process and regulates spreading and signalingCharanya Rengarajan, Alexandra Matzke, Luisa Reiner, et al.
Communications Biology|July 17, 2024
High-throughput screening for cell binding and repulsion peptides on multifunctionalized surfacesSteffen J Sonnentag, Felix Jenne, Véronique Orian-Rousseau, et al.
Genes & Development|December 5, 2002
CD44 is required for two consecutive steps in HGF/c-Met signalingVéronique Orian-Rousseau, Linfeng Chen, Jonathan P Sleeman, et al.
Cancers|March 6, 2021
Plasticity in Colorectal Cancer: Why Cancer Cells DifferentiateRomina Judith Walter, Steffen Joachim Sonnentag, Véronique Orian-Rousseau, et al.
Pageof 4